Perceptual Map Explanations

Perceptual Map explanation

In my Perceptual Map construction, I chose Fast acting/Slow release for the horizontal axis, and
General pain relief/Specific pain relief for my vertical axis. Evaluation and placement of the various types of pain relievers is solely based on information given to the consumer by the packaging and description given. Explanations are as follows and in no particular order:
Tylenol Extra Strength- I felt this placement was fairly straight forward with the information given. Key descriptors that jumped out at me were Extra Strength and Rapid Release. It was placed #1 for fast acting/ general pain relief. A key factor in my decision to place this medication
#1 was the dosage strength(500mg), which separated itself from
I placed it higher than other general pain relievers such as Aleve, Ibuprofen, Motrin, etc., but with lack of dosage information I could not place it as high as Tylenol Extra Strength on the pain relief axis. Also, I could not notice any definitive information that would tell me whether this medication was fast acting or slow acting so it was placed in a neutral area along that axis.
Aleve- This medication was placed on the general pain relief axis, and due to dosage strength of 220mg, was placed below Vanquish. There is also a general “pain reliever/fever reducer” caption, and no specific pain this medication targets. Also, there is no mention of how fast or slow this medication takes to provide relief, so it was neutral on that axis. (group of aleve,
Nuprin, Advil, Motrin, and bayer are all meant to be seen as neutral on the fast acting/slow release axis and due to overlapping, were placed in positions seen along that specific axis.)
Nuprin- This medication was placed below Aleve on the general pain relief axis due to the dosage strength of 200mg/capsule being slightly lower. Again, no mention of time of
Motrin- Placed alongside Nuprin and Advil on the general pain relief scale due to dosage strength 200mg. No mention of whether the medication is fast acting or a slow release capsule.
Observations: It seems Nuprin, Advil, and Motrin have no real advantage against the other when competing for consumer business. All are targeting the same group of potential customers, and it seems decisions made by customers in this area would be on brand experience and trust more than anything.
Bayer chewable- This medication was placed on the general pain relief axis but below all others in this category. the main reason is its 81mg dose. There is no real indication of time of release.
This medication does differentiate itself from others by being a chewable tablet, which has some appeal to specific consumers.

Excedrin- This medication specifically stated the ailment to be targeted, hence its placement on the specific pain relief axis. No mention of time of release is holding this medication back from being at the top of its specific market. Also, no dosing or strength mentioned on box.
Anacin- This medication is placed on the fast acting axis due to the specific labeling “Fast